|
01.04.2020 15:26:00
|
Karo Pharma Publishes the 2019 Annual Report
HUDDINGE, Sweden, April 1, 2020 /PRNewswire/ -- Today, on 1 April 2020, Karo Pharma is publishing its annual report for 2019 on the company's website, www.karopharma.com.
ABOUT KARO PHARMA
Karo Pharma specialises in the sales and marketing of prescription drugs and over the counter products for everyday healthcare. Karo Pharma is headquartered in Stockholm, Sweden, and quoted on Nasdaq Stockholm Mid Cap.
This information is information that Karo Pharma is obliged to make public pursuant to the Swedish Securities Market Act. The information was submitted for publication, through the agency of the contact person set out above, on 1 April, at 15:00 CET.
FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
Jon Johnsson, CFO
+46-735-078-861
jon.johnsson@karopharma.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/karo-pharma/r/karo-pharma-publishes-the-2019-annual-report,c3078843
The following files are available for download:
https://mb.cision.com/Main/72/3078843/1222434.pdf | Press release (PDF) |
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Karo Pharma ABmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Karo Pharma ABmehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.